Work

The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer

Year: 2020

Type: article

Study design: Observational Study

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-020-05837-6

Authors: Sudpreeda Chainitikun, James P. Long, Ruben Rodriguez-Bautista, Toshiaki Iwase, Debu Tripathy, Takeo Fujii, Naoto T. Ueno

Institutions: The University of Texas MD Anderson Cancer Center, Instituto Nacional de Cancerología

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: Center for Clinical and Translational Sciences (CCTS), Cancer Center Support Grant

OpenAlex ID: W3046002699

FWCI: 0.415

Cites: 20

Cited by: 9

Related to: 10